Global NGS Diagnostics for Rare Diseases Market: Transforming Precision Medicine Through Genomic Innovation
The global market for Next-Generation Sequencing (NGS) diagnostics in rare diseases is entering a phase of rapid expansion, driven by breakthroughs in genomic science, declining sequencing costs, and growing demand for early and precise diagnosis. Valued at USD 889 million in 2023, the market is projected to reach USD 2.26 billion by 2030, registering a … Read more